What's on

  • October 7, 2015

    A new review on bipolar disorder highlights the need of a translational approach of the disease

    Researchers from Hospital Clínic and IDIBAPS have published a review on bipolar disorder in the prestigious journal The Lancet. It is an update on the latest developments in tackling this disease, of which a complete vision is offered. Researchers emphasize in the importance of a translational approach of bipolar disorder and underline the need to search for biomarkers for a better diagnosis and a personalized treatment. The article has been coordinated by Dr. Eduard Vieta, head of the unit and research group on Bipolar Disorder at Hospital Clinic and IDIBAPS, and Dr. Iria Grande, specialist at the same team.

    Read the rest of this entry

  • September 29, 2015

    Dr. Jordi Bruix, new Scientific Director of the Networked Biomedical Research Center for Hepatic and Digestive Diseases

    Dr. Jordi Bruix, group leader of the Networked Biomedical Research Center for Hepatic and Digestive Diseases (CIBEREHD) at Hospital Clínic and IDIBAPS, has been appointed CIBEREHD Scientific Director on the CIBER Standing Committee (dependent on the Carlos III Health Institute) held this morning. Dr. Bruix succeeds Dr. Jaume Bosch, also from the Hospital Clinic of  and the IDIBAPS, who occupied this position since 2006.

    Read the rest of this entry

  • September 28, 2015

    A study defines the risk of colon cancer in patients with serrated polyposis

    A study led by researchers from Hospital Clínic and IDIBAPS defines more precisely the risk of developing colon cancer in patients with serrated polyposis, a syndrome in which colorectal polyps have a characteristic gear morphology. In a study published in the journal Gut, researchers have confirmed that this syndrome predisposes to colon cancer but with a lower risk than the previously published. Dr. Francesc Balaguer, head of the High Risk Colorectal Cancer Unit at Hospital Clínic of Barcelona and researcher at the Gastrointestinal and pancreatic oncology IDIBAPS team, has coordinated this study. The first author of the paper is Dr. Sabela Carballal, specialist at the Gastroenterology Department at Hospital Clinic.

    Read the rest of this entry

  • September 22, 2015

    IDIBAPS participates in a 5.7M European project to improve knowledge on liver cancer

    The Translational Reserarch in Hepatic Oncology IDIBAPS group, led by Dr. Josep M. Llovet, in collaboration with Dr. Roser Pinyol and 8 more researchers, participates in a European project to identify the molecular mechanisms that have a direct impact on the development of hepatocellular carcinoma (HCC). The HEP-CAR project will evaluate the role of these mechanisms in different liver diseases leading to HCC -the infection by hepatitis B and C, overweight or alcohol-. This research initiative, coordinated by the University of Freiburg and in which ten European academic centers are involved, is part of Horizon 2020, the European Comission framework programme for research and innovation, and it is endowed with a budget of 5.7 million euros, one of them corresponding to IDIBAPS.

    Read the rest of this entry

  • September 17, 2015

    Developed a DNA chip to better detect and lead the treatment of chronic lymphocytic leukemia

    Researchers from the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and the Hospital Clínic of Barcelona, in collaboration with qGenomics, have developed a DNA chip, or array, to analyze the genome and identify genetic abnormalities in chronic lymphocytic leukemia. This chip allows overcoming the limitations for the detection of changes of the current techniques, such as fluorescent in situ hybridization (FISH), and can be used for a more accurate diagnosis of the disease.

    Read the rest of this entry



  • Tuesday, 10/13/2015 · Seminar

    Prime Flow RNA Assay

    Neus Romo. Labclinics
     Esteve Auditorium. Rosselló 149, 08036 Barcelona
    3:00 PM
  • Monday, 10/26/2015 · IIBB Lecture Series

    Prof. Michael Karin

    Professor of Pharmacology and Pathology. School of Medicine University of California, San Diego

    The fat that feeds the fire: Understanding the pathogenesis of NASH and how it progresses to hepatocellular carcinoma
     Esteve Auditorium. c/ Rosselló 149-153, 08036 Barcelona
    3 PM
  • Wednesday, 12/02/2015 · International Symposium

    Biology meets technology for liver toxicity testing

    Several speakers
    Leuven, Belgium
    09:00 AM

More events